兰卫医学 (301060.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(兰卫医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 431,965,957.19425,322,271.83412,587,989.381,090,478,594.981,048,169,275.611,232,967,452.91827,689,742.45
 营业收入(元) 431,965,957.19425,322,271.83412,587,989.381,090,478,594.981,048,169,275.611,232,967,452.91827,689,742.45
二、营业总成本(元) 420,954,957.80412,261,059.72368,985,556.77883,566,608.48774,103,541.96864,661,427.38548,725,858.69
 营业成本(元) 336,352,726.43329,888,474.24292,605,731.41660,582,686.37651,467,627.95666,101,722.51430,734,220.45
 研发费用(元) 13,067,542.348,879,614.4910,753,900.8061,078,226.2716,614,979.7819,215,130.9112,493,191.61
 营业税金及附加(元) 1,501,255.11962,801.28961,532.292,080,733.821,153,559.331,080,470.941,154,142.84
 销售费用(元) 23,431,331.4625,000,393.9621,385,761.7147,579,954.7040,052,530.3054,926,070.4041,562,077.56
 管理费用(元) 46,132,086.1046,719,840.6842,502,572.94109,834,922.0661,115,253.88122,085,065.2562,505,373.68
 财务费用(元) 470,016.36809,935.07776,057.622,410,085.263,699,590.721,252,967.37276,852.55
  其中:利息费用(元) 2,329,989.391,727,691.252,178,526.982,899,463.123,239,183.821,564,528.45755,216.46
  其中:利息收入(元) 2,117,219.881,256,115.201,400,302.26887,509.26577,709.18630,873.90684,569.98
 资产减值损失(元) -5,563,497.12-1,998,936.56-700,768.12-130,134,513.79-2,113,780.58-2,087,974.12-2,035,705.90
 信用减值损失(元) 3,372,935.31-42,831,942.03-35,517,924.09-23,037,703.37-14,021,681.20-13,308,144.56-4,220,539.92
三、其他经营收益
 加:公允价值变动收益(元) ------1,664,161.13
 加:投资收益(元) -632,670.11-798,327.70-867,042.16-1,357,650.91-537,498.81807,844.451,835,388.79
  其中:对联营企业和合营企业的投资收益(元) -757,825.67-668,243.52-766,559.35-1,104,334.75---
 资产处置收益(元) 2,183,081.21-381,533.26-300,952.62-607,732.65111,302.5856,971.5176,303.89
 其他收益(元) 1,431,093.024,276,981.8116,326,865.984,770,106.051,141,847.58584,645.323,442,575.03
四、营业利润(元) 11,801,941.70-28,672,545.6322,542,611.6056,544,491.83258,645,923.22354,359,368.13279,726,066.78
 加:营业外收入(元) 44,309.0388,925.2367,546.341,463,414.1750,848.20-4,580.0679,185.62
 减:营业外支出(元) 202,761.972,173,670.662,982,502.9833,647,347.716,949,799.422,673,694.143,150,474.72
五、利润总额(元) 11,643,488.76-30,757,291.0619,627,654.9624,360,558.29251,746,972.00351,681,093.93276,654,777.68
 减:所得税费用(元) 3,214,260.612,630,137.504,036,640.2518,228,985.4145,532,839.1056,128,980.8645,497,433.20
六、净利润(元) 8,429,228.15-33,387,428.5615,591,014.716,131,572.88206,214,132.90295,552,113.07231,157,344.48
(一)按经营持续性分类
  持续经营净利润(元) 8,429,228.15-33,387,428.5615,591,014.716,131,572.88206,214,132.90295,552,113.07231,157,344.48
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 942,555.62-23,235,712.3621,413,081.3213,004,003.68173,770,427.59253,309,164.72177,239,159.96
  少数股东损益(元) 7,486,672.53-10,151,716.20-5,822,066.61-6,872,430.8032,443,705.3142,242,948.3553,918,184.52
 扣除非经常性损益后的净利润(元) -2,097,931.67-23,046,765.2610,970,668.6737,957,994.52178,177,013.08254,562,808.74173,781,718.39
七、每股收益
 一、基本每股收益(元) --0.060.050.030.430.630.44
 二、稀释每股收益(元) --0.060.050.030.430.630.44
九、综合收益总额(元) 8,429,228.15-33,387,428.5615,591,014.716,131,572.88206,214,132.90295,552,113.07231,157,344.48
 归属于母公司所有者的综合收益总额(元) 942,555.62-23,235,712.3621,413,081.3213,004,003.68173,770,427.59253,309,164.72177,239,159.96
 归属于少数股东的综合收益总额(元) 7,486,672.53-10,151,716.20-5,822,066.61-6,872,430.8032,443,705.3142,242,948.3553,918,184.52
公告日期 2023-10-282023-08-312023-04-272023-04-272022-10-282022-08-262022-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院